FRA:6IRA (Sweden)  
IRLAB Therapeutics AB logo

IRLAB Therapeutics AB

€ 3.05 (+0.99%) Aug 19
P/E:
38.98
P/B:
4.53
Market Cap:
€ 161.46M ($ 162.14M)
Enterprise V:
€ 127.25M ($ 127.78M)
Volume:
-
Avg Vol (2M):
-
Also Trade In:
Volume:
-
Market Cap €:
161.46M
Market Cap $:
162.14M
PE Ratio:
38.98
Avg Vol (2-Month):
-
Enterprise Value €:
127.25M
Enterprise Value $:
127.78M
PB Ratio:
4.53
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
IRLAB Therapeutics AB is a drug discovery and development company providing novel treatments for disorders of the brain. The company focuses on innovative treatments and quality of life for patients with neurological and psychiatric illnesses. It is engaged in programs targeting core dysfunctions in Parkinson's disease and dementias. In addition, it is also involved in the clinical development of novel compounds which aims at offering improved clinical benefit for patients with Parkinson's disease.
Name Current Vs Industry Vs History
Cash-To-Debt 62.85
Equity-to-Asset 0.85
Debt-to-Equity 0.02
Debt-to-EBITDA 0.13
Interest Coverage 223.7
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 17.09
Distress
Grey
Safe
Beneish M-Score 7432.99
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Book Growth Rate 14.4

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 17.27
9-Day RSI 29.62
14-Day RSI 36.45
6-1 Month Momentum % -1.23
12-1 Month Momentum % -43.21

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.23
Quick Ratio 6.23
Cash Ratio 5.96
Days Sales Outstanding 16.28

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7.9

Financials (Next Earnings Date:2022-08-24)

FRA:6IRA's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 21.279
EPS (TTM) (€) 0.084
Beta 0
Volatility % 47.99
14-Day RSI 36.45
14-Day ATR (€) 0.056051
20-Day SMA (€) 3.20775
12-1 Month Momentum % -43.21
52-Week Range (€) 2.71 - 5.74
Shares Outstanding (Mil) 51.87

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

IRLAB Therapeutics AB Filings

Document Form Filing Date
No Filing Data